High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031

icon1
USD 45.90 BN
MARKET SIZE, 2031
icon2
CAGR 10.7%
(2026-2031)
icon3
600
REPORT PAGES
icon4
735
MARKET TABLES

HIGH THROUGHPUT SCREENING MARKET SIZE, SHARE & GROWTH SNAPSHOT

high-throughput-screening-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global high-throughput screening (HTS) market is projected to grow from USD 27.66 billion in 2026 to USD 45.90 billion by 2031, at a CAGR of 10.7% during the forecast period. The market was valued at USD 26.43 billion in 2025. Growth in the high-throughput screening (HTS) market can mainly be attributed to factors such as the growing adoption of open, innovative models in pharmaceutical & biotechnology companies, rising government funding and venture capital investments, increasing R&D spending, and technological advancements in the high-throughput screening (HTS) market.

KEY TAKEAWAYS

  • BY REGION
    By region, North America accounted for the largest share of ~43.0% of the market in 2025.
  • BY OFFERING
    By offering, the products segment accounted for the largest share of ~85.0% of the market in 2025.
  • BY PRODUCT TYPE
    By product type, the reagents, kits, and consumables segment dominated the market, with a share of ~61.0% in 2025.
  • PRODUCT BY TECHNOLOGY
    AI-enabled & computational screening technologies are expected to register the highest CAGR during the forecast period.
  • PRODUCT BY WORKFLOW
    The high-throughput screening segment held the largest share of the HTS market in 2025.
  • PRODUCT BY END USER
    The pharmaceutical & biotechnology companies segment accounted for a larger share of the market in 2025.
  • SERVICE BY TYPE
    The data analysis & informatics services segment is projected to grow at the fastest CAGR during the forecast period.
  • SERVICE BY END USER
    By end user, the pharmaceutical & biotechnology companies segment dominated the market in 2025.
  • BY APPLICATION
    By application, the drug discovery & development segment dominated the market in 2025.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Companies such as Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Inc., and Merck KGaA were identified as the star players in the global HTS market, given their strong market share and product & service footprint.
  • COMPETITIVE LANDSCAPE - STARTUPS/SMES
    Companies such as HighRes Biosolutions, Creative Biolabs, and Axxam S.p.A., among others have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The high-throughput screening (HTS) market is expected to expand significantly in the next decade, driven by the need for faster, more scalable drug discovery workflows. Growth is supported by rising pharmaceutical and biotechnology R&D spending, increasing use of outsourced discovery models, and advances in automation, high-content screening, cell-based assays, and AI-enabled data analysis. Wider adoption of 3D cell cultures, organoids, and improved screening platforms is further strengthening market expansion.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact of customer-side business trends in the high-throughput screening (HTS) market is shaped by changing drug discovery priorities and research workflow needs. Key trends include the shift toward outsourced and collaborative discovery models, greater use of automated and AI-enabled screening platforms, and growing demand for biologically relevant assays such as cell-based, 3D culture, and organoid-based screening.

high-throughput-screening-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing R&D funding and increasing public & private investments
  • Growing adoption of lab automation and robotic screening platforms
RESTRAINTS
Impact
Level
  • High costs associated with HTS instruments
  • Complexity in assay development and validation
OPPORTUNITIES
Impact
Level
  • Increasing adoption of HTS technologies in emerging markets
  • Growing application of HTS in drug repurposing and personalized medicine
CHALLENGES
Impact
Level
  • Complexity in data management and analysis

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing R&D funding and increasing public & private investments

Growing R&D funding from pharmaceutical companies, biotechnology firms, government agencies, and private investors is a major driver for the high-throughput screening (HTS) market. As drug discovery programs become more complex, companies are investing in automated screening platforms to evaluate larger compound, gene, and cell libraries with better speed and accuracy. Public funding for translational research and academic drug discovery centers is also supporting wider adoption of HTS systems. In parallel, venture capital-backed biotech companies are increasingly using HTS to accelerate target validation and hit identification. These investments are strengthening demand for assay kits, reagents, microplate readers, liquid handlers, imaging systems, and outsourced screening services.

Restraint: High costs associated with HTS instruments

High costs associated with HTS instruments remain a key restraint, especially for small biotechnology firms, academic institutes, and emerging-market laboratories. Advanced platforms such as automated liquid handling systems, high-content imaging systems, robotic workstations, and integrated screening platforms require significant upfront capital investment. In addition, maintenance, software licenses, assay optimization, skilled labor, and facility requirements add to the total cost of ownership. These cost barriers often delay purchasing decisions or limit adoption to well-funded pharmaceutical companies and large research centers. As a result, some users prefer outsourcing HTS services rather than building a comprehensive in-house screening infrastructure.

Opportunity: Complexity in data management and analysis

Emerging markets present strong growth opportunities for HTS product and service providers due to expanding pharmaceutical R&D, growing CRO activity, and increasing government support for life science research. Countries across the Asia Pacific, Latin America, and the Middle East are investing in drug discovery infrastructure, academic screening centers, and biotechnology innovation hubs. The rising presence of local and global CROs is also increasing demand for microplate-based screening, assay kits, automation systems, and data analysis tools. Cost-efficient research operations in these regions make them attractive for outsourced discovery programs. As HTS awareness and infrastructure improve, emerging markets are expected to become important revenue pockets for both product suppliers and screening service providers.

Challenge: Stringent regulatory processes

The complexity of data management and analysis is a major challenge in the HTS market, as modern screening workflows generate large volumes of multidimensional data. High-content imaging, cell-based assays, label-free detection, and 3D models produce complex datasets that require advanced informatics, image analysis, statistical tools, and biological interpretation. Many laboratories face difficulties in integrating data from different instruments, software platforms, assay formats, and screening sites. Poor data quality, false positives, assay variability, and lack of standardized analysis workflows can affect hit selection and downstream decision-making. This creates a growing need for skilled bioinformaticians, robust software platforms, and AI-enabled analytics to improve the reliability of HTS outputs.

HIGH THROUGHPUT SCREENING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Partnered with DyNAbind to deploy a fragment-based DNA-encoded Chemical Library (DEL) platform, enabling simultaneous screening of over 370,000 fragment pairs against novel protein targets. Enabled access to large-scale DEL screening without requiring dedicated HTS infrastructure; broadened tractable chemical space for novel and difficult targets, delivering more trustworthy hit identification results with significantly reduced false-positive rates.
Implemented a cell painting-based phenotypic HTS platform integrated with machine learning to predict compound bioactivity across large libraries without running individual biochemical assays for each target | AstraZeneca researchers screened a structurally diverse set of 8,300 compounds in a cell painting assay, then trained ML models on single-point bioactivity data from their internal HTS database to predict and rank compound activity across multiple targets. The approach enabled prioritization of compounds for probability of activity, effectively using one high-content imaging screen to generate predictions across an entire compound library of ~1 million compounds—substantially reducing the number of individual assays required.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem consists of pharmaceutical & biotechnology companies (primary customers), HTS service providers (screening services), instrument & reagent suppliers, academic & research institutions, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive advancements in HTS technologies, enhance drug discovery processes, and develop new therapeutics.

high-throughput-screening-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

high-throughput-screening-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

High-throughput Screening (HTS) Market, by Offering

In 2025, the products segment accounted for the largest share of the high-throughput screening (HTS) market. This dominance is mainly driven by the recurring use of assay kits, reagents, consumables, microplates, compound libraries, instruments, automation platforms, and software across HTS workflows. Since most screening programs require repeated product consumption from assay setup to hit confirmation, products continue to generate a larger revenue base than services.

High-throughput Screening (HTS) Products Market, by Type

The reagents, kits, and consumables segment held the largest share of the HTS products market in 2025. These products are essential for conducting biochemical assays, cell-based assays, detection reactions, sample preparation, compound screening, and secondary validation. Their recurring usage, broad application across multiple assay formats, and high replacement demand make them the most commercially significant product category in HTS workflows.

High-throughput Screening (HTS) Products Market, by Technology

Cell-based screening technologies held the largest share of the HTS products market by technology in 2025. These technologies are widely used because they provide more biologically relevant insights than traditional biochemical assays by assessing compound effects in living cells. The growing use of phenotypic screening, high-content imaging, 3D cell models, organoids, and disease-relevant cellular assays further supports the dominance of cell-based screening in modern drug discovery.

High-throughput Screening (HTS) Services Market, by Type

Primary screening services accounted for the largest share of the HTS services market in 2025. This is because primary screening forms the core outsourced activity in early-stage discovery, where large compound, cell, or gene libraries are screened to identify initial hits. Pharmaceutical and biotechnology companies increasingly use specialized service providers to access automated platforms, assay expertise, compound libraries, and faster screening capacity without heavy in-house infrastructure investment.

High-throughput Screening (HTS) Market, by Application

The drug discovery & development segment accounted for the largest share of the HTS market in 2025. HTS is extensively used by pharmaceutical and biotechnology companies to screen large compound libraries, identify hits, validate targets, and support lead optimization. Its ability to improve screening speed, reduce early-stage discovery timelines, and support decision-making across small-molecule, biologics, and precision medicine pipelines makes drug discovery & development the leading application area.

REGION

Asia Pacific to be fastest-growing region in global high-throughput screening (HTS) market during forecast period

The Asia Pacific region is expected to record the fastest growth in the high-throughput screening (HTS) market during the forecast period. Growth is supported by expanding pharmaceutical and biotechnology R&D activity, increasing CRO presence, and rising investments in drug discovery infrastructure across China, India, Japan, South Korea, and other emerging markets. The region is also benefiting from cost-efficient research operations, growing biotech start-up activity, and increasing adoption of automated screening platforms, microplate-based assays, and advanced analytical tools. In addition, collaborations between global pharmaceutical companies, local CROs, academic institutes, and government-backed research organizations are helping strengthen HTS capabilities across the region.

high-throughput-screening-market Region

HIGH THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX

The company evaluation matrix provides information on the top 21 players offering HTS-related products & services and outlines each vendor's performance. In the HTS market, Thermo Fisher Scientific Inc. (US) leads with a strong market presence and a wide product & service portfolio. Eppendorf SE (Germany) (Emerging Leader) is gaining traction, with sustainable revenue growth and expanding geographic presence.

high-throughput-screening-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 26.43 Billion
Market Forecast in 2026 (Value) USD 27.66 Billion
Market Forecast in 2031 (Value) USD 45.90 Billion
Growth Rate CAGR of 10.7% from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • Products by Type:
    • Instruments; Reagents
    • Kits
    • and Consumables; Software & Informatics; Services
  • Products by Technology:
    • Biochemical Screening Technologies
    • Cell-based Screening Technologies
    • High-content Screening (HCS) Technologies
    • Label-free Screening Technologies
    • Microfluidic & Miniaturized Screening Technologies
    • 3D Cell Culture & Advanced Cellular Model Technologies
    • Ultra-high-throughput & Automation Technologies
    • AI-enabled & Computational Screening Technologies
  • Products by Workflow:
    • Assay Development & Optimization
    • Compound Library Preparation
    • High-throughput Screening
    • Data Analysis & Hit Identification
    • Hit Confirmation
    • Hit Validation & Characterization
  • Products by End User:
    • Pharmaceutical & Biotechnology Companies
    • CROs & CDMOs
    • Academic & Research Institutes
    • Other End Users
  • Services by Type:
    • Assay Development & Optimization Services
    • Compound Library Management Services
    • Primary Screening Services
    • Secondary Screening & Hit Confirmation Services
    • Hit Validation & Characterization Services
    • Data Analysis & Informatics Services
    • Other Services
  • Service by End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Other End Users
  • By Application:
    • Drug Discovery & Development
    • Basic Research & Functional Genomics
    • Toxicology & Safety Screening
    • Precision Medicine & Biomarker Discovery
    • Stem Cell & Regenerative Medicine Research
    • Other Applications
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: HIGH THROUGHPUT SCREENING MARKET REPORT CONTENT GUIDE

high-throughput-screening-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
HTS Products Market in North America & Europe
  • Country-level market estimation & forecast of HTS instruments, reagents & consumables, and software across key European markets
  • Market growth trends and adoption analysis by product type
  • Detailed company profiles of key regional competitors
  • Enables prioritized market entry and expansion planning
  • Helps assess regional demand dynamics and identify high-growth product categories
Outsourced HTS Services Opportunity by Customer Type
  • Custom assessment of demand for outsourced HTS services across big pharma, emerging biotech, academic research centers, CROs, and government-funded institutes
  • The analysis covered primary screening, assay development, secondary screening, hit confirmation, data analysis, and hit validation services
 Helps service providers identify the most attractive customer groups, define service bundles, and prioritize commercial efforts toward customers with limited in-house screening infrastructure

RECENT DEVELOPMENTS

  • April 2026 : Agilent Technologies, Inc. (US) launched the BioTek Cytation 9 Cell Imaging Multimode Reader, designed to support applications such as phenotypic screening, cellular assays, and drug discovery research.
  • February 2026 : Revvity launched the Opera Phenix OptIQ high-content screening system, EnVision Nexus One multimode plate reader, and the AssayMate workstation to expand the company’s portfolio across high-content imaging, detection, automation, and screening workflows for drug discovery applications.
  • January 2026 : Molecular Devices, LLC (US) partnered with Automata to integrate its imaging, microplate reader, and high-content screening systems with Automata’s LINQ platform, enabling more connected and AI-ready laboratory workflows.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
60
2
EXECUTIVE SUMMARY
 
 
 
 
 
66
3
PREMIUM INSIGHTS
 
 
 
 
 
72
4
MARKET OVERVIEW
Unlock growth by leveraging HTS technologies amidst rising investments and emerging market opportunities.
 
 
 
 
 
76
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
GROWING ADOPTION OF OPEN INNOVATIVE MODELS
 
 
 
 
 
 
4.2.1.2
TECHNOLOGICAL ADVANCEMENTS
 
 
 
 
 
 
4.2.1.3
GROWING R&D FUNDING AND INCREASING PUBLIC & PRIVATE INVESTMENTS
 
 
 
 
 
 
4.2.1.4
GROWING ADOPTION OF LAB AUTOMATION & ROBOTIC SCREENING PLATFORMS
 
 
 
 
 
 
4.2.1.5
INCREASING OUTSOURCING OF SCREENING ACTIVITIES TO CROS & CDMOS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COSTS ASSOCIATED WITH HTS INSTRUMENTS
 
 
 
 
 
 
4.2.2.2
COMPLEXITY IN ASSAY DEVELOPMENT AND VALIDATION
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
INCREASING ADOPTION OF HTS TECHNOLOGIES IN EMERGING MARKETS
 
 
 
 
 
 
4.2.3.2
GROWING APPLICATION OF HTS IN DRUG REPURPOSING AND PERSONALIZED MEDICINE
 
 
 
 
 
 
4.2.3.3
EXPANSION OF CRISPR, RNAI, AND FUNCTIONAL GENOMICS SCREENING
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
COMPLEXITY IN DATA MANAGEMENT AND ANALYSIS
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive dynamics and economic shifts shaping high-throughput screening's future landscape.
 
 
 
 
 
86
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 902730 & 902781)
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 902730& 902781)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
IMPACT OF 2025 US TARIFFS ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.10.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.10.4.1
US
 
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
 
5.10.4.3
ASIA PACIFIC
 
 
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.10.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.10.5.2
CROS & CDMOS
 
 
 
 
 
 
5.10.5.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
AI-driven innovations revolutionize high-throughput screening, reshaping patent landscapes and market readiness.
 
 
 
 
 
109
 
6.1
TECHNOLOGICAL ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
HIGH-CONTENT SCREENING
 
 
 
 
 
 
6.1.1.2
LABEL-FREE DETECTION
 
 
 
 
 
 
6.1.1.3
MICROFLUIDICS
 
 
 
 
 
6.1.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
LABORATORY AUTOMATION & ROBOTIC INTEGRATION
 
 
 
 
 
 
6.1.2.2
MASS SPECTROMETRY
 
 
 
 
 
 
6.1.2.3
FLOW CYTOMETRY
 
 
 
 
 
6.1.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
FRAGMENT-BASED DRUG DISCOVERY
 
 
 
 
 
 
6.1.3.2
BIOINFORMATICS & CHEMINFORMATICS
 
 
 
 
6.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
 
 
6.5.1
BEST PRACTICES IN HTS WORKFLOW
 
 
 
 
 
 
6.5.2
CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate global sustainability regulations and compliance for strategic advantage and eco-certification success.
 
 
 
 
 
120
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.3
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock strategic insights into buyer dynamics and unmet needs driving market profitability.
 
 
 
 
 
125
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
9
HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
129
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
RECURRING CONSUMABLES DEMAND, AUTOMATION UPGRADES, AND ADVANCED SCREENING PLATFORMS TO DRIVE MARKET GROWTH
 
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
RISING OUTSOURCING OF ASSAY DEVELOPMENT, PRIMARY SCREENING, AND DATA ANALYSIS TO DRIVE GROWTH OF HTS SERVICES MARKET
 
 
 
 
10
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 232 Data Tables
 
 
 
 
 
138
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
REAGENTS, KITS, AND CONSUMABLES
 
 
 
 
 
 
 
10.2.1
SCREENING ASSAY KITS
 
 
 
 
 
 
 
10.2.1.1
CELL-BASED ASSAYS
 
 
 
 
 
 
 
 
10.2.1.1.1
CELL VIABILITY ASSAYS
 
 
 
 
 
 
10.2.1.1.2
CYTOTOXICITY ASSAYS
 
 
 
 
 
 
10.2.1.1.3
REPORTER GENE ASSAYS
 
 
 
 
 
 
10.2.1.1.4
OTHER CELL-BASED ASSAYS
 
 
 
 
10.2.1.2
BIOCHEMICAL ASSAYS
 
 
 
 
 
 
 
 
10.2.1.2.1
ENZYME ASSAYS
 
 
 
 
 
 
10.2.1.2.2
KINASE ASSAYS
 
 
 
 
 
 
10.2.1.2.3
BINDING ASSAYS
 
 
 
 
 
 
10.2.1.2.4
OTHER BIOCHEMICAL ASSAYS
 
 
 
 
10.2.1.3
OTHER ASSAYS & KITS
 
 
 
 
 
10.2.2
BIOLOGICAL & CELL CULTURE REAGENTS
 
 
 
 
 
 
 
10.2.2.1
RISING USE OF DISEASE-RELEVANT CELLULAR MODELS TO STRENGTHEN DEMAND FOR BIOLOGICAL AND CELL CULTURE REAGENTS
 
 
 
 
 
10.2.3
COMPOUND LIBRARIES
 
 
 
 
 
 
 
10.2.3.1
EXPANSION OF FOCUSED AND REPURPOSE LIBRARIES TO SUPPORT COMPOUND LIBRARY DEMAND
 
 
 
 
 
10.2.4
DETECTION REAGENTS
 
 
 
 
 
 
 
10.2.4.1
INCREASING ADOPTION OF FLUORESCENCE, LUMINESCENCE, AND BIOMARKER-BASED READOUTS TO DRIVE DETECTION REAGENT USE
 
 
 
 
 
10.2.5
3D CELL CULTURE PRODUCTS
 
 
 
 
 
 
 
10.2.5.1
SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS
 
 
 
 
 
 
 
 
10.2.5.1.1
RISING DEMAND FOR MATRIX-SUPPORTED DISEASE MODELS TO DRIVE SCAFFOLD-BASED 3D CULTURE PRODUCT GROWTH
 
 
 
 
10.2.5.2
SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS
 
 
 
 
 
 
 
 
10.2.5.2.1
INCREASING USE OF SPHEROID-BASED SCREENING TO SUPPORT SCAFFOLD-FREE 3D CULTURE PRODUCT ADOPTION
 
 
 
 
10.2.5.3
OTHER 3D CELL CULTURE PRODUCTS
 
 
 
 
 
10.2.6
OTHER HTS CONSUMABLES
 
 
 
 
 
10.3
INSTRUMENTS
 
 
 
 
 
 
 
10.3.1
DETECTION & IMAGING SYSTEMS
 
 
 
 
 
 
 
10.3.1.1
MICROPLATE READERS
 
 
 
 
 
 
 
 
10.3.1.1.1
GROWING USE OF MULTIPLEXED BIOCHEMICAL AND CELL-BASED ASSAYS TO SUPPORT MICROPLATE READER DEMAND
 
 
 
 
10.3.1.2
HIGH-CONTENT SCREENING (HCS) & IMAGING SYSTEMS
 
 
 
 
 
 
 
 
10.3.1.2.1
INCREASING ADOPTION OF PHENOTYPIC SCREENING AND AI-BASED CELLULAR ANALYSIS TO DRIVE GROWTH OF HCS SYSTEMS
 
 
 
 
10.3.1.3
CELL ANALYSIS SYSTEMS
 
 
 
 
 
 
 
 
10.3.1.3.1
GROWING USE OF CELL-BASED SCREENING AND FUNCTIONAL BIOLOGY ASSAYS TO STRENGTHEN DEMAND FOR CELL ANALYSIS SYSTEMS
 
 
 
 
10.3.1.4
LABEL-FREE DETECTION SYSTEMS
 
 
 
 
 
 
 
 
10.3.1.4.1
RISING NEED FOR REAL-TIME BIOMOLECULAR INTERACTION ANALYSIS TO SUPPORT ADOPTION OF LABEL-FREE DETECTION SYSTEMS
 
 
 
 
10.3.1.5
MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS
 
 
 
 
 
 
 
 
10.3.1.5.1
ASSAY MINIATURIZATION TO DRIVE ADOPTION OF MICROFLUIDIC SCREENING SYSTEMS
 
 
 
10.3.2
LIQUID HANDLING & AUTOMATION SYSTEMS
 
 
 
 
 
 
 
10.3.2.1
INCREASING ASSAY MINIATURIZATION AND WORKFLOW STANDARDIZATION TO DRIVE GROWTH OF LIQUID HANDLING & AUTOMATION SYSTEMS
 
 
 
 
 
10.3.3
ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS
 
 
 
 
 
 
 
10.3.3.1
RISING DEPLOYMENT OF END-TO-END LABORATORY AUTOMATION SYSTEMS TO ACCELERATE ROBOTIC HTS PLATFORM ADOPTION
 
 
 
 
 
10.3.4
OTHER HTS INSTRUMENTS
 
 
 
 
 
10.4
SOFTWARE & INFORMATICS
 
 
 
 
 
 
 
10.4.1
BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS
 
 
 
 
11
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables
 
 
 
 
 
238
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
CELL-BASED SCREENING TECHNOLOGIES
 
 
 
 
 
 
 
11.2.1
INCREASING ADOPTION OF PHYSIOLOGICALLY RELEVANT PHENOTYPIC SCREENING WORKFLOWS TO STRENGTHEN CELL-BASED TECHNOLOGY DEMAND
 
 
 
 
 
11.3
ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES
 
 
 
 
 
 
 
11.3.1
GROWING DEMAND FOR SCALABLE ROBOTIC INFRASTRUCTURE & INTEGRATED AUTOMATION PLATFORMS TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.4
HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES
 
 
 
 
 
 
 
11.4.1
RISING ADOPTION OF AI-POWERED PHENOTYPIC IMAGING AND MULTIPARAMETRIC CELLULAR PROFILING TO ACCELERATE HCS TECHNOLOGY GROWTH
 
 
 
 
 
11.5
BIOCHEMICAL SCREENING TECHNOLOGIES
 
 
 
 
 
 
 
11.5.1
CONTINUED EXPANSION OF TARGET-BASED DRUG DISCOVERY PROGRAMS TO SUSTAIN BIOCHEMICAL SCREENING PRODUCT DEMAND
 
 
 
 
 
11.6
3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES
 
 
 
 
 
 
 
11.6.1
RISING ADOPTION OF ORGANOIDS, SPHEROIDS, AND TISSUE-LIKE SCREENING SYSTEMS TO ACCELERATE 3D CELLULAR TECHNOLOGY GROWTH
 
 
 
 
 
11.7
LABEL-FREE SCREENING TECHNOLOGIES
 
 
 
 
 
 
 
11.7.1
INCREASING USE OF REAL-TIME BINDING KINETICS AND BIOPHYSICAL PROFILING TO SUPPORT LABEL-FREE SCREENING ADOPTION
 
 
 
 
 
11.8
OTHER HTS TECHNOLOGIES
 
 
 
 
 
12
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
264
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
PRIMARY SCREENING
 
 
 
 
 
 
 
12.2.1
LARGE-SCALE COMPOUND SCREENING REQUIREMENTS TO SUSTAIN PRODUCT DEMAND ACROSS PRIMARY HTS WORKFLOWS
 
 
 
 
 
12.3
ASSAY DEVELOPMENT & OPTIMIZATION
 
 
 
 
 
 
 
12.3.1
RISING NEED FOR ROBUST, MINIATURIZED, AND AUTOMATION-COMPATIBLE ASSAYS TO SUPPORT ASSAY DEVELOPMENT PRODUCT DEMAND
 
 
 
 
 
12.4
HIT CONFIRMATION/SECONDARY SCREENING
 
 
 
 
 
 
 
12.4.1
RISING FOCUS ON HIT QUALITY ASSESSMENT AND FALSE-POSITIVE REDUCTION TO SUPPORT SECONDARY SCREENING PRODUCT DEMAND
 
 
 
 
 
12.5
DATA ANALYSIS & HIT IDENTIFICATION
 
 
 
 
 
 
 
12.5.1
INCREASING INTEGRATION OF AI-DRIVEN ANALYTICS AND IMAGE-BASED SCREENING DATA TO ACCELERATE HIT IDENTIFICATION WORKFLOWS
 
 
 
 
 
12.6
COMPOUND LIBRARY PREPARATION
 
 
 
 
 
 
 
12.6.1
EXPANSION OF LARGE-SCALE AND FOCUSED SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND PREPARATION PRODUCTS
 
 
 
 
 
12.7
HIT VALIDATION & CHARACTERIZATION
 
 
 
 
 
 
 
12.7.1
GROWING FOCUS ON PHENOTYPIC CHARACTERIZATION WORKFLOWS TO DRIVE HIT VALIDATION PRODUCT DEMAND
 
 
 
 
13
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
286
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
13.2.1
SUSTAINED BIOPHARMA R&D INVESTMENT AND AUTOMATION-LED DRUG DISCOVERY TO DRIVE HTS PRODUCT ADOPTION
 
 
 
 
 
13.3
CROS & CDMOS
 
 
 
 
 
 
 
13.3.1
RISING DISCOVERY OUTSOURCING AND CRO PLATFORM EXPANSION TO ACCELERATE HTS PRODUCT DEMAND
 
 
 
 
 
13.4
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
13.4.1
PUBLIC RESEARCH FUNDING AND TRANSLATIONAL BIOLOGY PROGRAMS TO SUPPORT HTS PRODUCT UPTAKE IN RESEARCH INSTITUTES
 
 
 
 
 
13.5
OTHER END USERS
 
 
 
 
 
14
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables
 
 
 
 
 
301
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PRIMARY SCREENING SERVICES
 
 
 
 
 
 
 
14.2.1
RISING HIGH-VOLUME SCREENING REQUIREMENTS TO DRIVE GROWTH OF PRIMARY HTS SCREENING SERVICES
 
 
 
 
 
14.3
ASSAY DEVELOPMENT & OPTIMIZATION SERVICES
 
 
 
 
 
 
 
14.3.1
INCREASING DEMAND FOR CUSTOMIZED AND MINIATURIZED ASSAYS TO SUPPORT ASSAY DEVELOPMENT SERVICE ADOPTION
 
 
 
 
 
14.4
SECONDARY SCREENING & HIT CONFIRMATION SERVICES
 
 
 
 
 
 
 
14.4.1
INCREASING EMPHASIS ON HIT VALIDATION AND SELECTIVITY ASSESSMENT TO SUPPORT SECONDARY SCREENING SERVICES
 
 
 
 
 
14.5
HIT VALIDATION & CHARACTERIZATION SERVICES
 
 
 
 
 
 
 
14.5.1
GROWING NEED FOR MECHANISM-OF-ACTION PROFILING TO STRENGTHEN HIT CHARACTERIZATION SERVICE ADOPTION
 
 
 
 
 
14.6
COMPOUND LIBRARY MANAGEMENT SERVICES
 
 
 
 
 
 
 
14.6.1
EXPANSION OF LARGE-SCALE SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND MANAGEMENT SERVICES
 
 
 
 
 
14.7
DATA ANALYSIS & INFORMATICS SERVICES
 
 
 
 
 
 
 
14.7.1
GROWING ADOPTION OF AI-ENABLED SCREENING ANALYTICS AND IMAGE-BASED DATA INTERPRETATION TO DRIVE HTS INFORMATICS SERVICES GROWTH
 
 
 
 
 
14.8
OTHER HTS SERVICES
 
 
 
 
 
15
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
325
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
15.2.1
INCREASING COMPLEXITY OF DRUG DISCOVERY WORKFLOWS TO STRENGTHEN OUTSOURCING OF HTS SERVICES BY PHARMA AND BIOTECH COMPANIES
 
 
 
 
 
15.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
15.3.1
LIMITED IN-HOUSE AUTOMATION CAPACITY TO DRIVE ACADEMIC OUTSOURCING OF HTS SERVICES
 
 
 
 
 
15.4
OTHER END USERS
 
 
 
 
 
16
HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 43 Data Tables
 
 
 
 
 
336
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
16.2.1
INCREASING PHARMACEUTICAL R&D INVESTMENTS AND EXPANSION OF TARGET-BASED AND PHENOTYPIC DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH
 
 
 
 
 
16.3
BASIC RESEARCH & FUNCTIONAL GENOMICS
 
 
 
 
 
 
 
16.3.1
GROWING ADOPTION OF CRISPR SCREENING, FUNCTIONAL GENOMICS, AND DISEASE PATHWAY CHARACTERIZATION TO DRIVE HTS DEMAND
 
 
 
 
 
16.4
TOXICOLOGY & SAFETY SCREENING
 
 
 
 
 
 
 
16.4.1
INCREASING EMPHASIS ON PREDICTIVE TOXICOLOGY AND REGULATORY PRESSURE TO REDUCE ANIMAL TESTING TO ACCELERATE HTS ADOPTION
 
 
 
 
 
16.5
PRECISION MEDICINE & BIOMARKER DISCOVERY
 
 
 
 
 
 
 
16.5.1
EXPANSION OF BIOMARKER-GUIDED THERAPEUTICS AND PERSONALIZED MEDICINE PIPELINES TO DRIVE RAPID GROWTH IN PRECISION MEDICINE SCREENING APPLICATIONS
 
 
 
 
 
16.6
STEM CELL & REGENERATIVE MEDICINE RESEARCH
 
 
 
 
 
 
 
16.6.1
GROWING DEVELOPMENT OF CELL THERAPIES AND REGENERATIVE MEDICINE PRODUCTS IS SUPPORTING HTS ADOPTION IN STEM CELL RESEARCH
 
 
 
 
 
16.7
OTHER APPLICATIONS
 
 
 
 
 
17
HIGH-THROUGHPUT SCREENING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 441 Data Tables.
 
 
 
 
 
357
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
NORTH AMERICA
 
 
 
 
 
 
 
17.2.1
US
 
 
 
 
 
 
 
17.2.1.1
ADVANCED AUTOMATION, STRONG DRUG DISCOVERY INFRASTRUCTURE, AND AI-ENABLED SCREENING WORKFLOWS TO SUPPORT MARKET GROWTH
 
 
 
 
 
17.2.2
CANADA
 
 
 
 
 
 
 
17.2.2.1
ACADEMIC SCREENING INFRASTRUCTURE TO SUPPORT MARKET GROWTH
 
 
 
 
17.3
EUROPE
 
 
 
 
 
 
 
17.3.1
GERMANY
 
 
 
 
 
 
 
17.3.1.1
INCREASING PRODUCT LAUNCHES AND INVESTMENTS TO BOOST MARKET GROWTH
 
 
 
 
 
17.3.2
UK
 
 
 
 
 
 
 
17.3.2.1
INDUSTRIAL-SCALE SCREENING ACCESS AND ACADEMIC HTS INFRASTRUCTURE TO SUPPORT MARKET
 
 
 
 
 
17.3.3
FRANCE
 
 
 
 
 
 
 
17.3.3.1
LARGE PHARMACEUTICAL R&D EXPENDITURE TO DRIVE MARKET GROWTH
 
 
 
 
 
17.3.4
ITALY
 
 
 
 
 
 
 
17.3.4.1
FUNCTIONAL GENOMICS AND AUTOMATED SCREENING PLATFORMS TO FUEL GROWTH
 
 
 
 
 
17.3.5
SPAIN
 
 
 
 
 
 
 
17.3.5.1
ACADEMIC SCREENING PLATFORMS, CHEMICAL BIOLOGY NETWORKS, AND ASSAY AUTOMATION TO BOOST MARKET
 
 
 
 
 
17.3.6
REST OF EUROPE
 
 
 
 
 
17.4
ASIA PACIFIC
 
 
 
 
 
 
 
17.4.1
CHINA
 
 
 
 
 
 
 
17.4.1.1
AUTOMATION-LED DRUG DISCOVERY AND CRO-LED SCREENING CAPACITY EXPANSION TO SUPPORT GROWTH OF MARKET
 
 
 
 
 
17.4.2
JAPAN
 
 
 
 
 
 
 
17.4.2.1
ADVANCED SCREENING PLATFORMS AND INTEGRATED DRUG DISCOVERY PARTNERSHIPS TO SUPPORT MARKET GROWTH
 
 
 
 
 
17.4.3
INDIA
 
 
 
 
 
 
 
17.4.3.1
AUTOMATION-LED CRO EXPANSION AND BIOPHARMA R&D INFRASTRUCTURE GROWTH TO FUEL MARKET
 
 
 
 
 
17.4.4
AUSTRALIA
 
 
 
 
 
 
 
17.4.4.1
ROBOTIC SCREENING INFRASTRUCTURE AND TRANSLATIONAL DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH
 
 
 
 
 
17.4.5
SOUTH KOREA
 
 
 
 
 
 
 
17.4.5.1
AI-ENHANCED SCREENING PLATFORMS AND TRANSLATIONAL R&D COLLABORATIONS TO FAVOR MARKET GROWTH
 
 
 
 
 
17.4.6
REST OF ASIA PACIFIC (ROAPAC)
 
 
 
 
 
17.5
LATIN AMERICA
 
 
 
 
 
 
 
17.5.1
BRAZIL
 
 
 
 
 
 
 
17.5.1.1
AUTOMATED BIOASSAY INFRASTRUCTURE AND DISEASE-FOCUSED DISCOVERY PROGRAMS TO DRIVE GROWTH
 
 
 
 
 
17.5.2
MEXICO
 
 
 
 
 
 
 
17.5.2.1
COST-EFFICIENT DISCOVERY CAPACITY, ANTIMICROBIAL RESEARCH, AND AUTOMATED ASSAY ADOPTION TO DRIVE GROWTH
 
 
 
 
 
17.5.3
REST OF LATIN AMERICA
 
 
 
 
 
17.6
MIDDLE EAST
 
 
 
 
 
 
 
17.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
17.6.1.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
17.6.1.1.1
GROWING PHARMACEUTICALS INDUSTRY TO SUPPORT MARKET GROWTH
 
 
 
 
17.6.1.2
UAE
 
 
 
 
 
 
 
 
17.6.1.2.1
PRECISION MEDICINE INVESTMENT, AUTOMATED LABORATORY INFRASTRUCTURE, AND AI-ENABLED DISCOVERY WORKFLOWS TO BOOST MARKET GROWTH
 
 
 
 
17.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
 
17.6.2
REST OF MIDDLE EAST
 
 
 
 
 
17.7
AFRICA
 
 
 
 
 
 
 
17.7.1
INFECTIOUS DISEASE RESEARCH AND SHARED DISCOVERY NETWORKS TO AID MARKET GROWTH
 
 
 
 
18
COMPETITIVE LANDSCAPE
Gain insights into strategic moves and market dominance of key HTS players and emerging startups.
 
 
 
 
 
565
 
18.1
OVERVIEW
 
 
 
 
 
 
18.2
KEY PLAYER STRATEGY/RIGHT TO WIN
 
 
 
 
 
 
 
18.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
18.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
18.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
18.5
COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
18.5.1
STARS
 
 
 
 
 
 
18.5.2
EMERGING LEADERS
 
 
 
 
 
 
18.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
18.5.4
PARTICIPANTS
 
 
 
 
 
 
18.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
18.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
18.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
18.5.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
18.5.5.4
PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
18.5.5.5
APPLICATION FOOTPRINT
 
 
 
 
18.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
18.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
18.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
18.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
18.6.4
STARTING BLOCKS
 
 
 
 
 
 
18.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
18.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
18.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
18.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
18.7.1
FINANCIAL METRICS
 
 
 
 
 
 
18.7.2
COMPANY VALUATION
 
 
 
 
 
18.8
BRAND/PRODUCT/SERVICE COMPARISON
 
 
 
 
 
 
18.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
18.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
18.9.2
DEALS
 
 
 
 
 
 
18.9.3
EXPANSIONS
 
 
 
 
19
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
587
 
19.1
KEY PLAYERS
 
 
 
 
 
 
 
19.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
19.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
19.1.1.2
PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
19.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
19.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
19.1.1.3.2
DEALS
 
 
 
 
 
 
19.1.1.3.3
EXPANSIONS
 
 
 
 
19.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
19.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
19.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
19.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
19.1.2
DANAHER CORPORATION
 
 
 
 
 
 
19.1.3
MERCK KGAA
 
 
 
 
 
 
19.1.4
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
19.1.5
REVVITY, INC.
 
 
 
 
 
 
19.1.6
TECAN GROUP LTD.
 
 
 
 
 
 
19.1.7
BIO-RAD LABORATORIES, INC.
 
 
 
 
 
 
19.1.8
CORNING INCORPORATED
 
 
 
 
 
 
19.1.9
METTLER-TOLEDO INTERNATIONAL INC.
 
 
 
 
 
 
19.1.10
LONZA GROUP
 
 
 
 
 
 
19.1.11
WATERS CORPORATION
 
 
 
 
 
 
19.1.12
SARTORIUS AG
 
 
 
 
 
 
19.1.13
EPPENDORF SE
 
 
 
 
 
 
19.1.14
PORVAIR PLC
 
 
 
 
 
 
19.1.15
GREINER AG
 
 
 
 
 
 
19.1.16
CHARLES RIVER LABORATORIES
 
 
 
 
 
 
19.1.17
EUROFINS SCIENTIFIC
 
 
 
 
 
 
19.1.18
HAMILTON COMPANY
 
 
 
 
 
 
19.1.19
AURORA BIOMED INC.
 
 
 
 
 
 
19.1.20
GILSON INCORPORATED
 
 
 
 
 
 
19.1.21
BRAND GMBH + CO KG
 
 
 
 
 
19.2
OTHER PLAYERS
 
 
 
 
 
 
 
19.2.1
BMG LABTECH GMBH
 
 
 
 
 
 
19.2.2
DIANA BIOTECHNOLOGIES, A.S.
 
 
 
 
 
 
19.2.3
CREATIVE BIOLABS
 
 
 
 
 
 
19.2.4
HIGHRES BIOSOLUTIONS
 
 
 
 
 
 
19.2.5
BIOMAT SRL
 
 
 
 
 
 
19.2.6
AXXAM S.P.A.
 
 
 
 
 
 
19.2.7
SYGNATURE DISCOVERY LIMITED
 
 
 
 
 
 
19.2.8
CROWN BIOSCIENCE
 
 
 
 
20
RESEARCH METHODOLOGY
 
 
 
 
 
695
 
20.1
RESEARCH DATA
 
 
 
 
 
 
 
20.1.1
SECONDARY DATA
 
 
 
 
 
 
 
20.1.1.1
KEY SECONDARY SOURCES
 
 
 
 
 
 
20.1.1.2
KEY DATA FROM SECONDARY RESEARCH
 
 
 
 
 
20.1.2
PRIMARY DATA
 
 
 
 
 
 
 
20.1.2.1
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
20.1.2.2
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
20.1.2.3
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
20.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
20.2.1
GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025
 
 
 
 
 
 
 
20.2.1.1
APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP)
 
 
 
 
 
 
20.2.1.2
APPROACH 2: PRIMARY RESEARCH
 
 
 
 
 
 
 
 
20.2.1.2.1
KEY INDUSTRY INSIGHTS
 
 
 
 
20.2.1.3
APPROACH 3: MNM REPOSITORY ANALYSIS
 
 
 
 
 
20.2.2
SEGMENTAL MARKET SIZE ESTIMATION, 2025
 
 
 
 
 
20.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
20.4
DATA TRIANGULATION
 
 
 
 
 
 
20.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
20.6
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
 
21
APPENDIX
 
 
 
 
 
709
 
21.1
DISCUSSION GUIDE
 
 
 
 
 
 
21.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
21.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
21.4
RELATED REPORTS
 
 
 
 
 
 
21.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
HIGH-THROUGHPUT SCREENING (HTS) MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 3
HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT OF PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 4
HIGH-THROUGHPUT SCREENING (HTS) MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 7
IMPORT VALUE FOR HS CODE 902730, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 8
IMPORT VOLUME FOR HS CODE 902730, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 9
IMPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
IMPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS)
 
 
 
 
 
 
TABLE 11
EXPORT VALUE FOR HS CODE 902730, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
EXPORT VOLUME FOR HS CODE 902730, BY COUNTRY, 2021–2025 (TONS)
 
 
 
 
 
 
TABLE 13
EXPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 14
EXPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS)
 
 
 
 
 
 
TABLE 15
HIGH-THROUGHPUT SCREENING (HTS) MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 16
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 17
HIGH-THROUGHPUT SCREENING (HTS) MARKET: INDICATIVE LIST OF PATENTS, 2026
 
 
 
 
 
 
TABLE 18
CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
TABLE 19
CLIENT’S READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING
 
 
 
 
 
 
TABLE 20
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
 
 
 
 
 
 
TABLE 25
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
 
 
 
 
 
 
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 27
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
TABLE 28
HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NORTH AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
EUROPE: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
ASIA PACIFIC: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
LATIN AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
MIDDLE EAST: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
GCC COUNTRIES: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
EUROPE: SCREENING ASSAY KITS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
EUROPE: CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
EUROPE: CELL VIABILITY ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
EUROPE: CYTOTOXICITY ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
EUROPE: REPORTER GENE ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
EUROPE: OTHER CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
ASIA PACIFIC: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
LATIN AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MIDDLE EAST: OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
GCC COUNTRIES: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
EUROPE: BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
NORTH AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
EUROPE: ENZYME ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
ASIA PACIFIC: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
LATIN AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
MIDDLE EAST: ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
GCC COUNTRIES: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
NORTH AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
EUROPE: KINASE ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
ASIA PACIFIC: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
LATIN AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
MIDDLE EAST: KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
GCC COUNTRIES: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
NORTH AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: BINDING ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
ASIA PACIFIC: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
LATIN AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
MIDDLE EAST: BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GCC COUNTRIES: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
EUROPE: OTHER BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
ASIA PACIFIC: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
LATIN AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
MIDDLE EAST: OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GCC COUNTRIES: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
EUROPE: OTHER ASSAYS & KITS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
NORTH AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
ASIA PACIFIC: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
LATIN AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
MIDDLE EAST: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GCC COUNTRIES: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
NORTH AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
EUROPE: COMPOUND LIBRARIES MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
ASIA PACIFIC: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
LATIN AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
MIDDLE EAST: COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GCC COUNTRIES: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
NORTH AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
EUROPE: DETECTION REAGENTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
ASIA PACIFIC: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
LATIN AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
MIDDLE EAST: DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
GCC COUNTRIES: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
EUROPE: 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
EUROPE: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
EUROPE: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NORTH AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
EUROPE: OTHER 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ASIA PACIFIC: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
LATIN AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
MIDDLE EAST: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
GCC COUNTRIES: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
NORTH AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
EUROPE: OTHER HTS CONSUMABLES MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ASIA PACIFIC: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
LATIN AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
MIDDLE EAST: OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
GCC COUNTRIES: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
EUROPE: HTS INSTRUMENTS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
MIDDLE EAST: HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
GCC COUNTRIES: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
HTS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
EUROPE: DETECTION & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
NORTH AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
EUROPE: MICROPLATE READERS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ASIA PACIFIC: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
LATIN AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
MIDDLE EAST: MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
GCC COUNTRIES: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
NORTH AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
EUROPE: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
ASIA PACIFIC: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
LATIN AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
MIDDLE EAST: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
GCC COUNTRIES: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
NORTH AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
EUROPE: CELL ANALYSIS SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
ASIA PACIFIC: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
LATIN AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
MIDDLE EAST: CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
GCC COUNTRIES: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
NORTH AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
EUROPE: LABEL-FREE DETECTION SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
ASIA PACIFIC: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
LATIN AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
MIDDLE EAST: LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
GCC COUNTRIES: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
NORTH AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
EUROPE: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
ASIA PACIFIC: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
LATIN AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
MIDDLE EAST: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
GCC COUNTRIES: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
NORTH AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
EUROPE: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
ASIA PACIFIC: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
LATIN AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
MIDDLE EAST: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
GCC COUNTRIES: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
NORTH AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
EUROPE: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
ASIA PACIFIC: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
LATIN AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
MIDDLE EAST: OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
GCC COUNTRIES: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
NORTH AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
EUROPE: HTS SOFTWARE & INFORMATICS MARKET, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
ASIA PACIFIC: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
LATIN AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
MIDDLE EAST: HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
GCC COUNTRIES: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
NORTH AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
EUROPE: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
ASIA PACIFIC: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
LATIN AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
MIDDLE EAST: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
GCC COUNTRIES: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
NORTH AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
EUROPE: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
ASIA PACIFIC: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
LATIN AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
MIDDLE EAST: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
GCC COUNTRIES: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
NORTH AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
EUROPE: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
ASIA PACIFIC: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
LATIN AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
MIDDLE EAST: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
GCC COUNTRIES: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
NORTH AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
EUROPE: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
ASIA PACIFIC: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
LATIN AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
MIDDLE EAST: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
GCC COUNTRIES: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
NORTH AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
EUROPE: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
ASIA PACIFIC: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
LATIN AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
MIDDLE EAST: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
GCC COUNTRIES: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
NORTH AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
EUROPE: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
ASIA PACIFIC: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
LATIN AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
MIDDLE EAST: LABEL-FREE SCREENING TECHNOLOGIES MARKE T, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
GCC COUNTRIES: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
NORTH AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
EUROPE: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
ASIA PACIFIC: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
LATIN AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
MIDDLE EAST: OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
GCC COUNTRIES: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
NORTH AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
EUROPE: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
ASIA PACIFIC: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
LATIN AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
MIDDLE EAST: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
GCC COUNTRIES: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
NORTH AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
EUROPE: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ASIA PACIFIC: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
LATIN AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
MIDDLE EAST: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
GCC COUNTRIES: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
EUROPE: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
NORTH AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
EUROPE: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
ASIA PACIFIC: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
LATIN AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
MIDDLE EAST: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
GCC COUNTRIES: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
NORTH AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
EUROPE: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
ASIA PACIFIC: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
LATIN AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
MIDDLE EAST: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
GCC COUNTRIES: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
EUROPE: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
NORTH AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
EUROPE: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
ASIA PACIFIC: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
LATIN AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
MIDDLE EAST: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
GCC COUNTRIES: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
NORTH AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
EUROPE: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
ASIA PACIFIC: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
LATIN AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
MIDDLE EAST: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
GCC COUNTRIES: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
NORTH AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
EUROPE: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
ASIA PACIFIC: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
LATIN AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
MIDDLE EAST: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
GCC COUNTRIES: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
NORTH AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
EUROPE: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
ASIA PACIFIC: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
LATIN AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
MIDDLE EAST: HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
GCC COUNTRIES: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
NORTH AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
EUROPE: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
ASIA PACIFIC: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
LATIN AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
MIDDLE EAST: PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
GCC COUNTRIES: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
NORTH AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
EUROPE: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
ASIA PACIFIC: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
LATIN AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
MIDDLE EAST: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
GCC COUNTRIES: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
NORTH AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
EUROPE: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
ASIA PACIFIC: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
LATIN AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
MIDDLE EAST: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
GCC COUNTRIES: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
NORTH AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
EUROPE: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
ASIA PACIFIC: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
LATIN AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
MIDDLE EAST: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
GCC COUNTRIES: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
NORTH AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
EUROPE: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
ASIA PACIFIC: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
LATIN AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
MIDDLE EAST: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
GCC COUNTRIES: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
NORTH AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
EUROPE: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
ASIA PACIFIC: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
LATIN AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
MIDDLE EAST: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
GCC COUNTRIES: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
NORTH AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
EUROPE: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
ASIA PACIFIC: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
LATIN AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
MIDDLE EAST: OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
GCC COUNTRIES: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
NORTH AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
EUROPE: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
ASIA PACIFIC: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
LATIN AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
MIDDLE EAST: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
GCC COUNTRIES: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
NORTH AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
EUROPE: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
ASIA PACIFIC: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
LATIN AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
MIDDLE EAST: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
GCC COUNTRIES: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
NORTH AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
EUROPE: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
ASIA PACIFIC: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
LATIN AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
MIDDLE EAST: HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
GCC COUNTRIES: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
EUROPE: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
MIDDLE EAST: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
GCC COUNTRIES: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
NORTH AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
EUROPE: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
ASIA PACIFIC: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
LATIN AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
MIDDLE EAST: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
GCC COUNTRIES: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
NORTH AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
EUROPE: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
ASIA PACIFIC: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
LATIN AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
MIDDLE EAST: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
GCC COUNTRIES: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
NORTH AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
EUROPE: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
ASIA PACIFIC: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
LATIN AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
MIDDLE EAST: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
GCC COUNTRIES: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
NORTH AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
EUROPE: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
ASIA PACIFIC: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
LATIN AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
MIDDLE EAST: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
GCC COUNTRIES: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
MIDDLE EAST: HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
GCC COUNTRIES: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
HIGH-THROUGHPUT SCREENING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
NORTH AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
NORTH AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
US: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
US: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
US: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
US: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
US: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
US: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
US: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
US: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 547
US: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 548
CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 549
CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 550
CANADA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 551
CANADA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 552
CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 553
CANADA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 554
CANADA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 555
CANADA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 556
CANADA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 557
CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 558
CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 559
CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 560
CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 561
CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 562
CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 563
EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 564
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 565
EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 566
EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 567
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 568
EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 569
EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 570
EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 571
EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 572
EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 573
EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 574
EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 575
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 576
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 577
EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 578
EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 579
EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 580
EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 581
GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 582
GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 583
GERMANY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 584
GERMANY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 585
GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 586
GERMANY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 587
GERMANY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 588
GERMANY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 589
GERMANY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 590
GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 591
GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 592
GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 593
GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 594
GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 595
GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 596
UK: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 597
UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 598
UK: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 599
UK: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 600
UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 601
UK: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 602
UK: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 603
UK: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 604
UK: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 605
UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 606
UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 607
UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 608
UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 609
UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 610
UK: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 611
FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 612
FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 613
FRANCE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 614
FRANCE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 615
FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 616
FRANCE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 617
FRANCE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 618
FRANCE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 619
FRANCE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 620
FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 621
FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 622
FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 623
FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 624
FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 625
FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 626
ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 627
ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 628
ITALY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 629
ITALY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 630
ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 631
ITALY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 632
ITALY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 633
ITALY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 634
ITALY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 635
ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 636
ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 637
ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 638
ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 639
ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 640
ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 641
SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 642
SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 643
SPAIN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 644
SPAIN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 645
SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 646
SPAIN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 647
SPAIN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 648
SPAIN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 649
SPAIN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 650
SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 651
SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 652
SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 653
SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 654
SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 655
SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 656
REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 657
REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 658
REST OF EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 659
REST OF EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 660
REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 661
REST OF EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 662
REST OF EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 663
REST OF EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 664
REST OF EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 665
REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 666
REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 667
REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 668
REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 669
REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 670
REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 671
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 672
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 673
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 674
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 675
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 676
ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 677
ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 678
ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 679
ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 680
ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 681
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 682
ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 683
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 684
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 685
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 686
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 687
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 688
ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 689
CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 690
CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 691
CHINA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 692
CHINA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 693
CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 694
CHINA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 695
CHINA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 696
CHINA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 697
CHINA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 698
CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 699
CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 700
CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 701
CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 702
CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 703
CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 704
JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 705
JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 706
JAPAN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 707
JAPAN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 708
JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 709
JAPAN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 710
JAPAN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 711
JAPAN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 712
JAPAN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 713
JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 714
JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 715
JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 716
JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 717
JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 718
JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 719
INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 720
INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 721
INDIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 722
INDIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 723
INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 724
INDIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 725
INDIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 726
INDIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 727
INDIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 728
INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 729
INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 730
INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 731
INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 732
INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 733
INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 734
AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 735
AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 736
AUSTRALIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 737
AUSTRALIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 738
AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 739
AUSTRALIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 740
AUSTRALIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 741
AUSTRALIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 742
AUSTRALIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 743
AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 744
AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 745
AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 746
AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 747
AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 748
AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 749
SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 750
SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 751
SOUTH KOREA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 752
SOUTH KOREA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 753
SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 754
SOUTH KOREA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 755
SOUTH KOREA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 756
SOUTH KOREA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 757
SOUTH KOREA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 758
SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 759
SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 760
SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 761
SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 762
SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 763
SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 764
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 765
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 766
REST OF ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 767
REST OF ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 768
REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 769
REST OF ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 770
REST OF ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 771
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 772
REST OF ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 773
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 774
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 775
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 776
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 777
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 778
REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 779
LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 780
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 781
LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 782
LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 783
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 784
LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 785
LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 786
LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 787
LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 788
LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 789
LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 790
LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 791
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 792
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 793
LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 794
LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 795
LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 796
LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 797
BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 798
BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 799
BRAZIL: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 800
BRAZIL: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 801
BRAZIL: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 802
BRAZIL: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 803
BRAZIL: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 804
BRAZIL: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 805
BRAZIL: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 806
BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 807
BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 808
BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 809
BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 810
BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 811
BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 812
MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 813
MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 814
MEXICO: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 815
MEXICO: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 816
MEXICO: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 817
MEXICO: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 818
MEXICO: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 819
MEXICO: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 820
MEXICO: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 821
MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 822
MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 823
MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 824
MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 825
MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 826
MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 827
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 828
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 829
REST OF LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 830
REST OF LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 831
REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 832
REST OF LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 833
REST OF LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 834
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 835
REST OF LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 836
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 837
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 838
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 839
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 840
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 841
REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 842
MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 843
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 844
MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 845
MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 846
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 847
MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 848
MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 849
MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 850
MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 851
MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 852
MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 853
MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 854
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 855
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 856
MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 857
MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 858
MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 859
MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 860
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 861
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 862
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 863
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 864
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 865
GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 866
GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 867
GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 868
GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 869
GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 870
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 871
GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 872
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 873
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 874
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 875
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 876
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 877
GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 878
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 879
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 880
SAUDI ARABIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 881
SAUDI ARABIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 882
SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 883
SAUDI ARABIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 884
SAUDI ARABIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 885
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 886
SAUDI ARABIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 887
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 888
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 889
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 890
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 891
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 892
SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 893
UAE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 894
UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 895
UAE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 896
UAE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 897
UAE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 898
UAE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 899
UAE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 900
UAE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 901
UAE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 902
UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 903
UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 904
UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 905
UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 906
UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 907
UAE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 908
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 909
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 910
REST OF GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 911
REST OF GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 912
REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 913
REST OF GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 914
REST OF GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 915
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 916
REST OF GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 917
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 918
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 919
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 920
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 921
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 922
REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 923
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 924
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 925
REST OF MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 926
REST OF MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 927
REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 928
REST OF MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 929
REST OF MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 930
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 931
REST OF MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 932
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 933
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 934
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 935
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 936
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 937
REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 938
AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 939
AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 940
AFRICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 941
AFRICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 942
AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 943
AFRICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 944
AFRICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 945
AFRICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 946
AFRICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 947
AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 948
AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 949
AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 950
AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 951
AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 952
AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 953
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET
 
 
 
 
 
 
TABLE 954
HIGH-THROUGHPUT SCREENING MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 955
HIGH-THROUGHPUT SCREENING MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 956
HIGH-THROUGHPUT SCREENING MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 957
HIGH-THROUGHPUT SCREENING MARKET: PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 958
HIGH-THROUGHPUT SCREENING MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 959
HIGH-THROUGHPUT SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 960
HIGH-THROUGHPUT SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION
 
 
 
 
 
 
TABLE 961
HIGH-THROUGHPUT SCREENING MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 962
HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 963
HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 964
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 965
THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 966
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 967
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 968
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 969
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 970
DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 971
DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 972
DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 973
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 974
MERCK KGAA: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 975
MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 976
MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 977
MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 978
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 979
AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 980
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 981
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 982
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 983
AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 984
REVVITY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 985
REVVITY INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 986
REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 987
REVVITY, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 988
TECAN GROUP LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 989
TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 990
TECAN GROUP LTD.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 991
TECAN GROUP LTD.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 992
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 993
BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 994
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 995
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 996
CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 997
METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 998
METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 999
LONZA GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1000
LONZA GROUP: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1001
WATERS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1002
WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1003
WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1004
WATERS CORPORATION: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1005
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1006
SARTORIUS AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1007
SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1008
SARTORIUS AG: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1009
SARTORIUS AG: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1010
EPPENDORF SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1011
EPPENDORF SE: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1012
EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1013
EPPENDORF SE: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1014
EPPENDORF SE: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1015
PORVAIR PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1016
PORVAIR PLC: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1017
GREINER AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1018
GREINER AG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1019
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1020
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1021
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1022
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1023
EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1024
EUROFINS SCIENTIFIC: SERVICE LAUNCHES
 
 
 
 
 
 
TABLE 1025
EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1026
EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1027
HAMILTON COMPANY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1028
HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1029
HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1030
HAMILTON COMPANY: DEALS, JANUARY 2023–APRIL 2026
 
 
 
 
 
 
TABLE 1031
AURORA BIOMED INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1032
AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1033
GILSON INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1034
GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1035
BRAND GMBH + CO KG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1036
BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
 
 
 
 
 
 
TABLE 1037
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 1038
RISK ASSESSMENT
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
HTS MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
REGIONS CONSIDERED
 
 
 
 
 
 
FIGURE 3
HIGH-THROUGHPUT SCREENING MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 4
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 5
GLOBAL HIGH-THROUGHPUT SCREENING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 7
DISRUPTIONS INFLUENCING GROWTH OF HIGH-THROUGHPUT SCREENING MARKET
 
 
 
 
 
 
FIGURE 8
HIGH-GROWTH SEGMENTS IN HIGH-THROUGHPUT SCREENING MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HIGH-THROUGHPUT SCREENING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
GROWING ADOPTION OF OPEN INNOVATIVE MODELS TO DRIVE MARKET GROWTH
 
 
 
 
 
 
FIGURE 11
US AND REAGENTS, KITS, AND CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH-THROUGHPUT SCREENING MARKET IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 12
ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL HIGH-THROUGHPUT SCREENING MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 14
HIGH-THROUGHPUT SCREENING (HTS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 15
HIGH-THROUGHPUT SCREENING (HTS) MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 16
GLOBAL GDP GROWTH (2020–2030)
 
 
 
 
 
 
FIGURE 17
HIGH-THROUGHPUT SCREENING (HTS) MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 18
HIGH-THROUGHPUT SCREENING (HTS) MARKET ECOSYSTEM
 
 
 
 
 
 
FIGURE 19
AVERAGE SELLING PRICE TREND OF LIQUID HANDLING SYSTEMS, BY KEY PLAYER, 2023–2025 (USD)
 
 
 
 
 
 
FIGURE 20
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 21
REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
FIGURE 22
TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 23
IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET
 
 
 
 
 
 
FIGURE 24
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 25
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 26
FLOW CYTOMETRY INSTRUMENTS (CELL ANALYZERS) MARKET, 2024–2031 (UNITS)
 
 
 
 
 
 
FIGURE 27
NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 28
ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 29
REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 30
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 31
HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 32
HIGH-THROUGHPUT SCREENING MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 33
HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 34
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 36
HIGH-THROUGHPUT SCREENING MARKET: BRAND/PRODUCT/SERVICE COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 37
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
REVVITY, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
TECAN GROUP LTD.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
LONZA GROUP: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
WATERS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 48
SARTORIUS AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
EPPENDORF SE: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 50
PORVAIR PLC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 51
GREINER AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 52
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 53
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 54
HIGHT-THROUGHPUT SCREENING MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 55
HIGHT-THROUGHPUT SCREENING MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 56
GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025
 
 
 
 
 
 
FIGURE 57
HIGH-THROUGHPUT SCREENING MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)
 
 
 
 
 
 
FIGURE 58
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025)
 
 
 
 
 
 
FIGURE 59
HIGH-THROUGHPUT SCREENING MARKET: INSIGHTS FROM PRIMARIES
 
 
 
 
 
 
FIGURE 60
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 61
HIGH-THROUGHPUT SCREENING MARKET: CAGR PROJECTIONS
 
 
 
 
 
 
FIGURE 62
HTS MARKET: DATA TRIANGULATION
 
 
 
 
 
 

Methodology

This research study relied heavily on secondary sources, directories, and databases to identify and collect valuable information for analyzing the global high-throughput screening (HTS) market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the high-throughput screening (HTS) market. The secondary sources used for this study include World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), National Center for Advancing Translational Sciences (NCATS), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Health Service (NHS), Pharmaceuticals and Medical Devices Agency (PMDA), European Medicines Agency (EMA), Society for Laboratory Automation and Screening (SLAS), European Bioinformatics Institute, and Center for Translational Research, among others. Corporate filings include annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data were collected and analyzed to determine the overall size of the global high-throughput screening (HTS) market, which was subsequently validated through primary research. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

High-Throughput Screening (HTS) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were employed to estimate and validate the overall size of the high-throughput screening (HTS) market. These methods were also widely used to determine the size of various market segments. The research methodology used to estimate the market size includes the following:

High-Throughput Screening (HTS) Market : Top-Down and Bottom-Up Approach

High-Throughput Screening (HTS) Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size, the total market was divided into segments and subsegments. Data triangulation and market breakdown techniques were used where applicable to finalize the overall market analysis and obtain precise statistics for all segments and subsegments. The data was triangulated by examining various factors and trends from both demand and supply sides.

Market Definition

High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays.

The HTS market comprises products (instruments, reagents & consumables, software), and services used to perform automated, parallel screening of large compound or biological libraries against defined biological targets or assays to identify active entities (hits). The high-throughput screening (HTS) market comprises workflow stages from assay development and compound library management to automated large-scale screening and hit identification, culminating in validated screening hits.

Key Stakeholders

  • Contract research organizations
  • Pharmaceutical & biopharmaceutical companies
  • Academic & research institutes
  • High-throughput screening instrument & reagent manufacturers
  • High-content screening database, service, and software providers
  • Venture capitalists & investors
  • Market research & consulting firms
  • Government associations
  • Medical institutions & universities

Report Objectives

  • To define, describe, and forecast the high-throughput screening (HTS) market by offering, products by type, products by technology, products by workflow, products by end user, services by type, services by end user, application, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall high-throughput screening (HTS) market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product & service launches, agreements, partnerships, acquisitions, and research & development activities
  • To analyze and provide funding & investment activities, brand/product/service comparative analysis, and vendor valuation & financial metrics of the high-throughput screening (HTS) market

Customization Options

Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product/Service Matrix gives a detailed comparison of the product/service portfolios of the top five companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Geographical Analysis

  • Further breakdown of the Rest of Europe high-throughput screening (HTS) market, by country
  • Further breakdown of the Rest of Asia Pacific high-throughput screening (HTS) market, by country
  • Further breakdown of the Rest of Latin America high-throughput screening (HTS) market, by country

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the High-Throughput Screening (HTS) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in High-Throughput Screening (HTS) Market

DMCA.com Protection Status